Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;38:902-906
doi: 10.1161/hy1001.091781
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rahmouni, K.
Right arrow Articles by De Jong, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rahmouni, K.
Right arrow Articles by De Jong, W.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Genetics of cardiovascular disease

(Hypertension. 2001;38:902.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Involvement of Brain Mineralocorticoid Receptor in Salt-Enhanced Hypertension in Spontaneously Hypertensive Rats

Kamal Rahmouni; Mariette Barthelmebs; Michèle Grima; Jean-Louis Imbs; Wybren De Jong

From the Institut de Pharmacologie, Faculté de Médecine, Université Louis Pasteur (K.R., M.B., M.G., J.-L.I., W. De J.), Strasbourg, France; and Service d’Hypertension Artérielle, Maladies Vasculaires et Pharmacologie Clinique, Hôpitaux Universitaires de Strasbourg (M.G., J.-L.I.), France.

Correspondence to Kamal Rahmouni, PhD, University of Iowa, 524 MRC, Iowa City, IA 52242. E-mail kamal-rahmouni{at}uiowa.edu

Abstract— We recently showed that brain mineralocorticoid receptors (MRs) are involved in blood pressure and kidney function control in normotensive Wistar rats. We now assessed the involvement of brain MRs in spontaneously hypertensive rats (SHR), in which the presence of adrenocorticoids has been shown to be required for the development of hypertension. The effect of a single intracerebroventricular (ICV) injection of an MR antagonist (RU28318) on systolic blood pressure (SBP) and renal function was examined in conscious adult SHR and Wistar-Kyoto rats (WKY) maintained on a standard-sodium diet (0.4% Na+). In WKY, a long-lasting decrease in SBP was caused by the ICV injection of 10 ng RU28318 as previously reported in Wistar rats, associated with increased urinary excretion of water and electrolytes. In SHR maintained on the standard diet, the ICV injection of RU28318 (10 or 100 ng) had no effect on cardiovascular and renal functions. However, the ICV injection of 10 ng RU28318 in SHR after 3 weeks of high sodium intake (8% Na+) caused a long-lasting decrease in SBP. The effect was present at 8 hours ({Delta}SBP 34±2 mm Hg), persisted at 24 hours ({Delta}SBP 29±1 mm Hg), and disappeared at 48 hours after the injection. The hypotension was not associated with changes in heart rate, urinary excretion of water and electrolytes, and plasma renin activity, whereas renal denervation did not affect the decrease in SBP. A more pronounced decrease in SBP (49±3 mm Hg at 8 hours) was observed with 100 ng RU28318. This dose of the antagonist was without effect after subcutaneous administration. Thus, brain MRs appear to participate in the maintenance of hypertension in conscious adult SHR sensitized by sodium loading.


Key Words: brain • mineralocorticoids • rats, inbred SHR • sodium • rats, inbred WKY




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. V. Menon, D. Arbique, Z. Wang, B. Adams-Huet, R. J. Auchus, and W. Vongpatanasin
Differential Effects of Chlorthalidone Versus Spironolactone on Muscle Sympathetic Nerve Activity in Hypertensive Patients
J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1361 - 1366.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. S. Huang, R. A. White, M. Ahmad, A. Y. Jeng, and F. H. H. Leenen
Central infusion of aldosterone synthase inhibitor prevents sympathetic hyperactivity and hypertension by central Na+ in Wistar rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R166 - R172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. S. Huang, W. J. Cheung, H. Wang, J. Tan, R. A. White, and F. H. H. Leenen
Activation of brain renin-angiotensin-aldosterone system by central sodium in Wistar rats
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1109 - H1117.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. S. Huang, H. Wang, and F. H. H. Leenen
Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H517 - H524.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. B. de Paula, A. A. da Silva, and J. E. Hall
Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration
Hypertension, January 1, 2004; 43(1): 41 - 47.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Wang, B. S. Huang, and F. H. H. Leenen
Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2516 - H2523.
[Abstract] [Full Text] [PDF]